Effects of chronic Δ9-tetrahydrocannabinol treatment on hippocampal extracellular acetylcholine concentration and alternation performance in the T-maze
- 30 September 2001
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 41 (3) , 392-399
- https://doi.org/10.1016/s0028-3908(01)00075-2
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Inhibition of hippocampal acetylcholine release after acute and repeated Δ9-tetrahydrocannabinol in ratsPublished by Elsevier ,1998
- Chronic cannabinoid, CP-55,940, administration alters biotransformation in the ratEuropean Journal of Pharmacology, 1996
- Role of cyclic AMP in the actions of cannabinoid receptorsBiochemical Pharmacology, 1996
- Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid‐mediated blockade of long‐term potentiation in the rat hippocampal sliceBritish Journal of Pharmacology, 1995
- Pharmacology of memory: cholinergic—glutamatergic interactionsCurrent Opinion in Neurobiology, 1995
- Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performancePsychopharmacology, 1994
- A microdialysis and automated on-line analysis approach to study central cholinergic transmission in vivoPublished by Elsevier ,1991
- Δ9-Tetrahydroeannabinol enhances presynaptic dopamine efflux In medial prefrontal cortexEuropean Journal of Pharmacology, 1990
- Acute and chronic effects of ?9-Tetrahydrocannabinol on complex behavior of squirrel monkeysPsychopharmacology, 1980
- Absence of cerebral atrophy in chronic cannabis users. Evaluation by computerized transaxial tomographyPublished by American Medical Association (AMA) ,1977